NIH Ends Funding for Animal‑Only Studies: What This Means for Biomedical Research and 3D Cell Culture
The National Institutes of Health (NIH) has announced a major policy change: ending funding for...
Read News →
Latest News
Gelomics Achieves Triple ISO Certification, Reinforcing Global Leadership in Biomedical Innovation
We’re proud to share an exciting milestone for the Gelomics team: we’ve officially been awarded ISO...
Read News →
Industry Growth Program Grant Announcement
Gelomics Awarded $948K Industry Growth Program Grant to Accelerate Commercialisation of AI-Powered...
Read News →
Gelomics Partners with Morpho Biotech for Benelux Distribution
At Gelomics, we are committed to making cutting-edge, animal-free research tools more accessible to...
Read News →
Gelomics Partners with BioNordika Group to Expand Presence Across the Nordics and Baltics
Gelomics Partners with BioNordika Group to Expand Presence Across the Nordics and Baltics We’re...
Read News →
Gelomics Welcomes Distinguished Professor Gail Risbridger to its Scientific Advisory Board
Gelomics, a pioneering Australian biotech firm redefining the future of drug development with its...
Read News →
Past Events
Watch Gelomics’ latest on-demand Webinar!
Watch Gelomics' latest on-demand Webinar! Join Emma Morris as she explores the future of 3D cell...
View Event →
Conference | Join Gelomics at AACR 2025 in Chicago
Conference | Join Gelomics at AACR 2025 in Chicago We’re excited to showcase our latest innovations...
View Event →
On-demand Seminar | LunaGel™ Transforming 3D Cell Culture for Biomedical Breakthroughs
On-demand Seminar | LunaGel™ Transforming 3D Cell Culture for Biomedical Breakthroughs Discover the...
View Event →